The group consists of 5 scientists, 3 postdocs, 5 PhD students, 6 research engineers and one MD-PhD student.
We seek to reach a more fundamental understanding of the biological dynamics of breast cancer through high-throughput molecular analyses of DNA, mRNA, miRNA and protein. We
perform "state of the art" analyses of patient material, both on bulk tumors, single cells and liquid biopsies, at various stages of the disease, from consecutive series (OsloVal, Oslo0, Oslo1 and Oslo2) and from clinic trials with sampling before, during, and after therapy (the NeoAva and the IBCT-study).
Professor Anne-Lise Børresen-Dale, Email: email@example.com
Department of Cancer Genetics, Institute for Cancer Research
The Norwegian Radium Hospital, N-0310 Oslo,Norway
Phone: +47 2278 1373, Fax: +47 2278 1395, Switchboard: +47 2293 4000
Growth coordination during development
Mar 27, 2017
Jørgen Wesche appointed group leader for the Mesenchymal Cancer Biology Group at the Department of Tumor Biology
Mar 15, 2017
Prestigious research prize from the Norwegian Cancer Society to pioneer in autophagy research
Mar 7, 2017
Mar 6, 2017
BRCA2 hypomorphic missense variants confer moderate risks of breast cancer
Cancer Res (in press)